4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-25-015483
Director acquired 1,576 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kemps-Polanco Reshema Director | 2025-05-21 | Grant or award | +946 | $134.98 | $127,691 | 1,960 | D: show line 1 in the form |
| Kemps-Polanco Reshema Director | 2025-05-21 | Grant or award | +630 | $134.98 | $85,037 | 2,590 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kemps-Polanco Reshema Director | 2025-05-21 | Grant or award · Stock Options (Right to Buy) | +2,076 | $134.98 | $280,218 | 2,076 | D: show line 3 in the form |
Loading xslF345X05/form4.xml…